salicylaldehyde isonicotinoyl hydrazone and Leukemia, Promyelocytic, Acute

salicylaldehyde isonicotinoyl hydrazone has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adamcová, M; Gersl, V; Hasková, P; Hroch, M; Kaiserová, H; Ponka, P; Popelová, O; Simůnek, T; Sterba, M	1

Other Studies

1 other study(ies) available for salicylaldehyde isonicotinoyl hydrazone and Leukemia, Promyelocytic, Acute

Article	Year
Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone. British journal of pharmacology, 2008, Volume: 155, Issue:1 Topics: Aldehydes; Animals; Animals, Newborn; Antibiotics, Antineoplastic; Cell Proliferation; Cell Survival; Cytoprotection; Daunorubicin; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Hydrazones; Iron Chelating Agents; Leukemia, Promyelocytic, Acute; Lipid Peroxidation; Malondialdehyde; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Wistar; Time Factors	2008

Article

Year

Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.

British journal of pharmacology, 2008, Volume: 155, Issue:1

Topics: Aldehydes; Animals; Animals, Newborn; Antibiotics, Antineoplastic; Cell Proliferation; Cell Survival; Cytoprotection; Daunorubicin; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Hydrazones; Iron Chelating Agents; Leukemia, Promyelocytic, Acute; Lipid Peroxidation; Malondialdehyde; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Wistar; Time Factors

2008